Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment
Cancer Colorectal Cancer (CRC) Metastatic Colorectal Cancer
For the latest version of this information please go to www.forpatients.roche.com